Dettol: Marketing Research for Understanding Consumer Evaluations of Brand Extensions Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics:

• Reckitt Benckiser (RB) global revenue growth driven by power brands, specifically Dettol.
• Dettol brand equity valuation: consistently ranked as a top antiseptic/disinfectant brand in Asia and the Middle East.
• Brand extension success rate: historical data suggests 70-80% of new product launches fail within the FMCG sector.

Operational Facts:

• Product Portfolio: Core antiseptic liquid, soap, hand wash, surface cleaners.
• Geographic Focus: High penetration in India, China, and Southeast Asia.
• Methodology: Consumer evaluation of brand extensions depends on perceived fit (category similarity) and brand strength.

Stakeholder Positions:

• Management: Seeking to maximize brand equity through line extensions (e.g., personal care, skincare).
• Consumers: Exhibit high trust in Dettol for hygiene, but skepticism regarding efficacy in beauty/skincare categories.

Information Gaps:

• Specific P&L breakdown for proposed new product categories (e.g., Dettol skincare).
• Cannibalization rates between existing soap variants and proposed new extensions.
• Quantitative survey data on consumer perception of brand elasticity.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question:

• Should Dettol extend into the premium skincare category, or does this risk diluting the core antiseptic brand promise?

Structural Analysis:

• Brand Elasticity: Dettol is a functional, trust-based brand. Extending into emotional, beauty-centric categories (skincare) creates a category dissonance.
• Value Chain: The current supply chain excels at mass-market hygiene production. Skincare requires different distribution channels and higher marketing spend to compete with established beauty incumbents.

Strategic Options:

• Option 1: The Hygiene-Plus Extension. Extend into skin hygiene (e.g., acne-control soap) rather than general beauty. Rationale: Maintains functional alignment. Trade-off: Lower price point than premium skincare.
• Option 2: The Sub-Brand Strategy. Launch a new brand under the Dettol umbrella (e.g., Dettol Care) to distance the core brand from the new product. Rationale: Protects core. Trade-off: High marketing cost to build a sub-brand.
• Option 3: Status Quo. Focus on geographic expansion and core category penetration. Rationale: Zero risk to brand equity. Trade-off: Missed growth in premium segments.

Preliminary Recommendation: Option 1. Align extensions with the core hygiene promise to avoid brand dilution.

3. Implementation Roadmap (Implementation Specialist)

Critical Path:

• Phase 1 (Months 1-3): Quantitative consumer testing on perceived fit for acne-control variants.
• Phase 2 (Months 4-6): Pilot launch in a single high-trust market (e.g., India).
• Phase 3 (Months 7-12): Scale based on repeat purchase metrics, not trial volume.

Key Constraints:

• Brand Dissonance: Consumers equate Dettol with clinical antiseptic smell; this must be managed in product formulation.
• Channel Conflict: Retailers may prioritize existing Dettol SKUs over new, unproven variants.

Risk-Adjusted Strategy:

• Limit R&D investment to existing manufacturing lines to minimize capital expenditure.
• If pilot retention falls below 25% in the first quarter, terminate the extension immediately to preserve the core brand.

4. Executive Review and BLUF (Executive Critic)

BLUF:

Dettol should reject entry into the premium skincare market. The brand equity is rooted in clinical hygiene; attempting to pivot into beauty creates a high probability of brand dilution without a corresponding increase in market share. The company must focus on expanding its share of the hygiene market through functional, problem-solving extensions like acne-control soaps rather than chasing premium beauty margins. The core asset is consumer trust in efficacy; do not gamble it on an unproven category move.

Dangerous Assumption:

The analysis assumes that brand strength in hygiene is transferable to beauty. There is no evidence that consumers desire a clinical brand in their beauty routine.

Unaddressed Risks:

• Brand Dilution: If the skincare line fails, it associates the Dettol name with failure, impacting core antiseptic sales. Probability: High. Consequence: Severe.
• Retailer Pushback: Shelf space is finite. Replacing high-turnover antiseptic soap with low-turnover skincare risks losing primary shelf space. Probability: Moderate. Consequence: Significant.

Unconsidered Alternative:

Acquisition of a smaller, established skincare brand that can be improved by Dettol’s supply chain, while keeping the brands separate. This avoids the risk of forced brand extension.

Verdict: APPROVED FOR LEADERSHIP REVIEW.